Abstract

I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease

Author(s): McElhiney Linda F

Issue: May/Jun 2012 - Volume 16, Number 3

Page(s): 190-195

Download in electronic PDF format for $75
  • I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease Page 1
  • I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease Page 2
  • I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease Page 3
  • I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease Page 4
  • I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease Page 5
  • I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease Page 6

Abstract

Vital dyes have been used for over a hundred years to assist ophthalmic practitioners in diagnosing their patients’ problems. Patients don’t always tolerate the commercial products, usually due to the preservatives, and may need a compounded preparation. Some dyes are not commercially available, such as the brilliant blue G, and compounders who specialize in high-risk compounded sterile preparations are needed to meet these needs of the ophthalmologists. This article discusses some of these staining agents, including their properties.

Related Keywords

  • vital dyes
  • ophthalmic stains
  • ocular pathology
  • eye disorders
  • formulations
  • cornea lesions
  • corneal abrasions
  • keratitis
  • preservatives
  • compounded sterile preparations
  • microbial contamination
  • ophthalmic solutions
  • fluorescein
  • rose bengal
  • dry eye
  • keratoconjunctivitis sicca
  • lissamine green B
  • brilliant blue G
  • intravitreal administration

Related Categories

  • FORMULATIONS
  • OPHTHALMICS
  • STERILE PREPARATIONS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
May/Jun 2012
Pg. 190-195
I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease
Author(s): McElhiney Linda F
Sep/Oct 2016
Pg. 399-404
Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions
Author(s): Allen Loyd V Jr
Nov/Dec 2016
Pg. 495-500
Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments
Author(s): Allen Loyd V Jr
Nov/Dec 2009
Pg. 506-515
Autologous Eye Drops for the Treatment of Dry Eye and Neurotrophic Keratitis
Author(s): Mixon William, Angelle Patricea (Patsy), Chang Richard I
Jul/Aug 2004
Pg. 277-283
Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 2
Author(s): Davidson Gigi S
May/Jun 2004
Pg. 169-172
Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 1
Author(s): Davidson Gigi S
Sep/Oct 2004
Pg. 359-367
Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 3
Author(s): Davidson Gigi S
Jul/Aug 2003
Pg. 288-291
Basics of Compounding for Raynaud's Disease
Author(s): Glasnapp Andrew
Sep/Oct 2010
Pg. 421
Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution
Author(s): Allen Loyd V Jr
Nov/Dec 2006
Pg. 411-414
Compounding for Feline Herpetic Keratitis
Author(s): Davidson Gigi S
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Sep/Oct 2016
Pg. 367-374
Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy
Author(s): Kochanowska-Karamyan Anna J
Jan/Feb 2017
Pg. 62
Infliximab 1% Ophthalmic Solution
Author(s): Allen Loyd V Jr
May/Jun 2019
Pg. 221-228
Basics of Sterile Compounding: Vehicles Used in Sterile Compounding
Author(s): Allen Loyd V Jr
Nov/Dec 2015
Pg. 508
Dexamethasone Sodium Phosphate Ophthalmic Solution: Equivalent to 0.1% Dexamethasone Phosphate
Author(s): Allen Loyd V Jr
Sep/Oct 2014
Pg. 418-426
Stability and In Vitro Toxicity of an Infliximab Eye Drop Formulation
Author(s): Robert Marie-Claude, Spurr-Michaud Sandra, Frenette Mathieu, Young David, Gipson Ilene K, Dohlman Claes H
May/Jun 2015
Pg. 242
Atropine Sulfate 1% Ophthalmic Solution
Author(s): Allen Loyd V Jr
Nov/Dec 2004
Pg. 452-456
Cleaning of Isolators: A Vital Part of a Contamination Control Program
Author(s): Rossington Karen
May/Jun 2003
Pg. 188-191
Treating Canine Hepatic Disease
Author(s): Davidson Gigi S
Mar/Apr 2001
Pg. 92-94
Feline Ophthalmic Disease: Feline Herpesvirus and Systemic Hypertension
Author(s): Davidson Michael G